2 recruiting, 1 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Lipodystrophy, Partial, Acquired: new trials by email Literature Review of Lipodystrophy, Partial, Acquired trials Research Report on Lipodystrophy, Partial, Acquired
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024 Tirzepatide, Usual care medications - Lipodystrophy, Partial | Phase 2 | Recruiting | University of Michigan | 32 | 2025-09-08 | 2025-09-09 |
| Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance Pegvisomant - Insulin Receptor Mutation, Partial Lipodystrophy | Phase 2 | Recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 25 | 2023-01-23 | 2026-08-18 |
| Trial of Leptin Replacement Therapy in Patients With Lipodystrophy Leptin, Placebo - Hypoleptinemia, Generalized Lipodystrophy | Phase 2 / Phase 3 | Completed | University of Texas Southwestern Medical Center | 25 | 2006-04-01 | 2024-03-27 |
Insulin Resistance (2) · Lipodystrophy (1) · Lipodystrophy, Congenital Generalized (1)
Glucose Metabolism Disorders (2) · Hyperinsulinism (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Lipid Metabolism Disorders (1) · Lipid Metabolism, Inborn Errors (1) · Metabolism, Inborn Errors (1) · Skin Diseases (1) · Skin Diseases, Metabolic (1) · Skin and Connective Tissue Diseases (1)
Leptin (1) · Tirzepatide (1) · pegvisomant (1) · recombinant methionyl human leptin (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · University of Michigan (1) · University of Texas Southwestern Medical Center (1)
United States (3)
Abhimanyu Garg, MD (1) · Elif Oral, MD (1) · Rebecca J Brown, M.D. (1)